Infinium Pharmachem Limited engages in the manufacture and supply of iodine, iodine derivatives, and active pharmaceutical ingredients (APIs) in India and internationally. The company provides iodine based molecules/APIs/iodination reaction based bulk drugs. It also offers potassium iodide and iodate, sodium iodide, iodine, povidone iodine, pralidoxime iodide, thymol iodide, and iodoform products. In addition, the company provides contract research and manufacturing services to pharmaceutical and biotech companies for iodine based APIs and intermediates. It serves pharmaceutical and biotech, specialty and performance chemicals, dairy, food and nutraceutical, animal care, agrochemical, paints, coatings, dyes and textile, ink, paper and printing, rubber and nylon tyre, oil and gas, gold imitation and jewelry, medical, radiography, nuclear science, gemological, renewable energy, electrical, electronics, mechanical, aquarium, photography, tobacco, and fireworks, as well as cosmetics, sanit
| Current Price | ₹205.05 |
|---|---|
| Market Cap | ₹323 Cr |
| Sector | Health Care > Pharmaceuticals, Biotechnology and Life Sciences > Pharmaceuticals |
| Sub-Industry | Pharmaceuticals > Health Care; Pharmaceuticals, Biotechnology and Life Sciences; Pharmaceuticals; Pharmaceuticals; Medicinal Chemicals and Botanical Products; Pharmaceutical Contract Manufacturing Services |
| P/E Ratio | 26.3 |
| 52-Week Range | ₹189.40 – ₹297.00 |
| Beta (1Y) | 0.24 |
Infinium Pharmachem Limited is trading at ₹205.05, with a market capitalisation of ₹323 Cr.
Infinium Pharmachem Limited operates in the Health Care > Pharmaceuticals, Biotechnology and Life Sciences > Pharmaceuticals space (Pharmaceuticals > Health Care; Pharmaceuticals, Biotechnology and Life Sciences; Pharmaceuticals; Pharmaceuticals; Medicinal Chemicals and Botanical Products; Pharmaceutical Contract Manufacturing Services).
Infinium Pharmachem Limited has a P/E of 26.3.